|
[1]
|
Pagani, K., Lukac, D., Bhukhan, A. and McGee, J.S. (2022) Cutaneous Manifestations of Inflammatory Bowel Disease: A Basic Overview. American Journal of Clinical Dermatology, 23, 481-497. [Google Scholar] [CrossRef] [PubMed]
|
|
[2]
|
Park, S.H. and Park, S.H. (2022) Personalized Medicine in Inflammatory Bowel Disease: Perspectives on Asia. Journal of Gastroenterology and Hepatology, 37, 1434-1445. [Google Scholar] [CrossRef] [PubMed]
|
|
[3]
|
Pardi, D.S., Tremaine, W.J., Sandborn, W.J. and McCarthy, J.T. (1998) Renal and Urologic Complications of Inflammatory Bowel Disease. American Journal of Gastroenterology, 93, 504-514. [Google Scholar] [CrossRef] [PubMed]
|
|
[4]
|
Liu, T., Wu, Y., Cao, X., Yang, K., Tong, Y., Zhang, F., et al. (2024) Association between Sarcopenia and New-Onset Chronic Kidney Disease among Middle-Aged and Elder Adults: Findings from the China Health and Retirement Longitudinal Study. BMC Geriatrics, 24, Article No. 134. [Google Scholar] [CrossRef] [PubMed]
|
|
[5]
|
Plonsky-Toder, M., Magen, D. and Pollack, S. (2023) Innate Immunity and CKD: Is There a Significant Association? Cells, 12, Article 2714. [Google Scholar] [CrossRef] [PubMed]
|
|
[6]
|
Pattrapornpisut, P., Avila-Casado, C. and Reich, H.N. (2021) IgA Nephropathy: Core Curriculum 2021. American Journal of Kidney Diseases, 78, 429-441. [Google Scholar] [CrossRef] [PubMed]
|
|
[7]
|
Rodrigues, J.C., Haas, M. and Reich, H.N. (2017) IgA Nephropathy. Clinical Journal of the American Society of Nephrology, 12, 677-686. [Google Scholar] [CrossRef] [PubMed]
|
|
[8]
|
Ambruzs, J.M., Walker, P.D. and Larsen, C.P. (2014) The Histopathologic Spectrum of Kidney Biopsies in Patients with Inflammatory Bowel Disease. Clinical Journal of the American Society of Nephrology, 9, 265-270. [Google Scholar] [CrossRef] [PubMed]
|
|
[9]
|
Nakayama, T., Kaneko, H., Okada, A., Suzuki, Y., Fujiu, K., Takeda, N., et al. (2024) Association of Inflammatory Bowel Disease with Incident IgA Nephropathy. Clinical Journal of the American Society of Nephrology, 19, 704-711. [Google Scholar] [CrossRef] [PubMed]
|
|
[10]
|
Rehnberg, J., Symreng, A., Ludvigsson, J.F. and Emilsson, L. (2020) Inflammatory Bowel Disease Is More Common in Patients with IgA Nephropathy and Predicts Progression of ESKD: A Swedish Population-Based Cohort Study. Journal of the American Society of Nephrology, 32, 411-423. [Google Scholar] [CrossRef] [PubMed]
|
|
[11]
|
Joher, N., Gosset, C., Guerrot, D., Pillebout, E., Hummel, A., Boffa, J., et al. (2021) Immunoglobulin a Nephropathy in Association with Inflammatory Bowel Diseases: Results from a National Study and Systematic Literature Review. Nephrology Dialysis Transplantation, 37, 531-539. [Google Scholar] [CrossRef] [PubMed]
|
|
[12]
|
Barratt, J., Kristensen, J., Pedersen, C. and Jerling, M. (2024) Insights on Nefecon®, a Targeted-Release Formulation of Budesonide and Its Selective Immunomodulatory Effects in Patients with Iga Nephropathy. Drug Design, Development and Therapy, 18, 3415-3428. [Google Scholar] [CrossRef] [PubMed]
|
|
[13]
|
Floege, J. (2024) IgA-Nephropathie. Die Urologie, 63, 103-111. [Google Scholar] [CrossRef] [PubMed]
|
|
[14]
|
Lafayette, R., Kristensen, J., Stone, A., Floege, J., Tesař, V., Trimarchi, H., et al. (2023) Efficacy and Safety of a Targeted-Release Formulation of Budesonide in Patients with Primary IgA Nephropathy (NefigArd): 2-Year Results from a Randomised Phase 3 Trial. The Lancet, 402, 859-870. [Google Scholar] [CrossRef] [PubMed]
|
|
[15]
|
Bian, J., Liebert, A., Bicknell, B., Chen, X., Huang, C. and Pollock, C.A. (2022) Faecal Microbiota Transplantation and Chronic Kidney Disease. Nutrients, 14, Article 2528. [Google Scholar] [CrossRef] [PubMed]
|
|
[16]
|
Liu, M., Zhang, Y., Ye, Z., Yang, S., Zhou, C., He, P., et al. (2023) Inflammatory Bowel Disease with Chronic Kidney Disease and Acute Kidney Injury. American Journal of Preventive Medicine, 65, 1103-1112. [Google Scholar] [CrossRef] [PubMed]
|
|
[17]
|
Singh, A., Khanna, T., Mahendru, D., Kahlon, J., Kumar, V., Sohal, A., et al. (2024) Insights into Renal and Urological Complications of Inflammatory Bowel Disease. World Journal of Nephrology, 13, Article 96574. [Google Scholar] [CrossRef] [PubMed]
|
|
[18]
|
Saha, M.K., Hogan, S.L., Falk, R.J., Barnes, E.L., Hu, Y., Kshirsagar, A.V., et al. (2024) Acute Kidney Injury in Inflammatory Bowel Disease Patients: A Nationwide Comparative Analysis. Kidney Medicine, 6, Article 100836. [Google Scholar] [CrossRef] [PubMed]
|
|
[19]
|
Yang, Y., Ludvigsson, J.F., Forss, A., Faucon, A., Faye, A.S., Olén, O., et al. (2024) Risk of Kidney Failure in Patients with Inflammatory Bowel Disease Undergoing Colectomy: A Nationwide Cohort Study. Clinical Gastroenterology and Hepatology, 22, 2291-2298.E17. [Google Scholar] [CrossRef] [PubMed]
|
|
[20]
|
Joyce, E., Glasner, P., Ranganathan, S. and Swiatecka-Urban, A. (2016) Tubulointerstitial Nephritis: Diagnosis, Treatment, and Monitoring. Pediatric Nephrology, 32, 577-587. [Google Scholar] [CrossRef] [PubMed]
|
|
[21]
|
van Hoeve, K. and Hoffman, I. (2022) Renal Manifestations in Inflammatory Bowel Disease: A Systematic Review. Journal of Gastroenterology, 57, 619-629. [Google Scholar] [CrossRef] [PubMed]
|
|
[22]
|
Dimke, H., Winther-Jensen, M., Allin, K.H., Lund, L. and Jess, T. (2021) Risk of Urolithiasis in Patients with Inflammatory Bowel Disease: A Nationwide Danish Cohort Study 1977-2018. Clinical Gastroenterology and Hepatology, 19, 2532-2540.E2. [Google Scholar] [CrossRef] [PubMed]
|
|
[23]
|
Wu, H., Liu, P., Gong, S., Liu, X., Hill, M.A., Liu, Z., et al. (2023) Inflammatory Bowel Disease Increases the Levels of Albuminuria and the Risk of Urolithiasis: A Two-Sample Mendelian Randomization Study. European Journal of Medical Research, 28, Article No. 167. [Google Scholar] [CrossRef] [PubMed]
|
|
[24]
|
Ambruzs, J.M. and Larsen, C.P. (2018) Renal Manifestations of Inflammatory Bowel Disease. Rheumatic Disease Clinics of North America, 44, 699-714. [Google Scholar] [CrossRef] [PubMed]
|
|
[25]
|
Nazzal, L., Puri, S. and Goldfarb, D.S. (2015) Enteric Hyperoxaluria: An Important Cause of End-Stage Kidney Disease. Nephrology Dialysis Transplantation, 31, 375-382. [Google Scholar] [CrossRef] [PubMed]
|
|
[26]
|
Bernstein, C.N., Blanchard, J.F., Kliewer, E. and Wajda, A. (2001) Cancer Risk in Patients with Inflammatory Bowel Disease: A Population-Based Study. Cancer, 91, 854-862. [Google Scholar] [CrossRef]
|
|
[27]
|
Feng, D., Bai, Y., Liu, S., Yang, Y., Han, P. and Wei, W. (2021) Risk of Renal Cancer in Patients with Inflammatory Bowel Disease: A Pooled Analysis of Population-Based Studies. Urologic Oncology: Seminars and Original Investigations, 39, 93-99. [Google Scholar] [CrossRef] [PubMed]
|
|
[28]
|
Derikx, L.A.A.P., Nissen, L.H.C., Drenth, J.P.H., van Herpen, C.M., Kievit, W., Verhoeven, R.H.A., et al. (2015) Better Survival of Renal Cell Carcinoma in Patients with Inflammatory Bowel Disease. Oncotarget, 6, 38336-38347. [Google Scholar] [CrossRef] [PubMed]
|
|
[29]
|
Hall, E.C., Segev, D.L. and Engels, E.A. (2013) Racial/Ethnic Differences in Cancer Risk after Kidney Transplantation. American Journal of Transplantation, 13, 714-720. [Google Scholar] [CrossRef] [PubMed]
|
|
[30]
|
Maisonneuve, P., Agodoa, L., Gellert, R., Stewart, J.H., Buccianti, G., Lowenfels, A.B., et al. (1999) Cancer in Patients on Dialysis for End-Stage Renal Disease: An International Collaborative Study. The Lancet, 354, 93-99. [Google Scholar] [CrossRef] [PubMed]
|
|
[31]
|
Vajravelu, R.K., Copelovitch, L., Osterman, M.T., Scott, F.I., Mamtani, R., Lewis, J.D., et al. (2020) Inflammatory Bowel Diseases Are Associated with an Increased Risk for Chronic Kidney Disease, Which Decreases with Age. Clinical Gastroenterology and Hepatology, 18, 2262-2268. [Google Scholar] [CrossRef] [PubMed]
|
|
[32]
|
Sattianayagam, P.T., Gillmore, J.D., Pinney, J.H., Gibbs, S.D.J., Wechalekar, A.D., Gilbertson, J.A., et al. (2013) Inflammatory Bowel Disease and Systemic AA Amyloidosis. Digestive Diseases and Sciences, 58, 1689-1697. [Google Scholar] [CrossRef] [PubMed]
|
|
[33]
|
Meijers, B.K.I. and Evenepoel, P. (2011) The Gut-Kidney Axis: Indoxyl Sulfate, P-Cresyl Sulfate and CKD Progression. Nephrology Dialysis Transplantation, 26, 759-761. [Google Scholar] [CrossRef] [PubMed]
|
|
[34]
|
Kriz, W. and Lehir, M. (2005) Pathways to Nephron Loss Starting from Glomerular Diseases—Insights from Animal Models. Kidney International, 67, 404-419. [Google Scholar] [CrossRef] [PubMed]
|
|
[35]
|
Ranganathan, P., Jayakumar, C., Santhakumar, M. and Ramesh, G. (2013) Netrin-1 Regulates Colon-Kidney Cross Talk through Suppression of IL-6 Function in a Mouse Model of DSS-Colitis. American Journal of Physiology-Renal Physiology, 304, F1187-F1197. [Google Scholar] [CrossRef] [PubMed]
|
|
[36]
|
Kellum, J.A., Romagnani, P., Ashuntantang, G., Ronco, C., Zarbock, A. and Anders, H. (2021) Acute Kidney Injury. Nature Reviews Disease Primers, 7, Article No. 52. [Google Scholar] [CrossRef] [PubMed]
|
|
[37]
|
Schetz, M., Dasta, J., Goldstein, S. and Golper, T. (2005) Drug-Induced Acute Kidney Injury. Current Opinion in Critical Care, 11, 555-565. [Google Scholar] [CrossRef] [PubMed]
|
|
[38]
|
Bennett, W.M. (1995) The Nephrotoxicity of Immunosuppressive Drugs. Clinical Nephrology, 43, S3-S7.
|
|
[39]
|
Oikonomou, K.A., Kapsoritakis, A.N., Stefanidis, I. and Potamianos, S.P. (2011) Drug-Induced Nephrotoxicity in Inflammatory Bowel Disease. Nephron Clinical Practice, 119, c89-c96. [Google Scholar] [CrossRef] [PubMed]
|
|
[40]
|
Den Broeder, A.A., Assmann, K.J., Van Riel, P.L., et al. (2003) Nephrotic Syndrome as a Complication of Anti-TN Falpha in a Patient with Rheumatoid Arthritis. The Netherlands Journal of Medicine, 61, 137-141.
|
|
[41]
|
Tosca Cuquerella, J., Bosca-Watts, M.M., Anton Ausejo, R., Tejedor Alonso, S., Mora De Miguel, F. and Minguez Perez, M. (2016) Amyloidosis in Inflammatory Bowel Disease: A Systematic Review of Epidemiology, Clinical Features, and Treatment. Journal of Crohn’s and Colitis, 10, 1245-1253. [Google Scholar] [CrossRef] [PubMed]
|
|
[42]
|
Guillo, L., Delanaye, P., Flamant, M., Figueres, L., Karam, S., Lemoine, S., et al. (2022) Kidney Function Monitoring in Inflammatory Bowel Disease: The MONITORED Consensus. Digestive and Liver Disease, 54, 309-315. [Google Scholar] [CrossRef] [PubMed]
|
|
[43]
|
Zhao, L., Ren, G., Fan, R., Feng, X., Liu, Z., Cheng, Z., et al. (2021) Spectrum and Prognosis of Renal Histopathological Lesions in Patients with Inflammatory Bowel Disease: A Cross-Sectional Study from a Single Center in China. Clinical and Experimental Medicine, 22, 629-635. [Google Scholar] [CrossRef] [PubMed]
|